“Hypertension as a Cardiovascular Toxicity of Bruton’s Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia” (2025) Canadian Hematology Today, 4(s03), pp. 2–12. doi:10.58931/cht.2025.4s0368.